Riskpilot← Back to searchSign inGet full accessBIOVITA AS
ASActiveOrg 990631697Holterkollveien 6, 1448 DrøbakRetail sale of other food · NACE 4727Est. 20066 employees
Revenue 2024
NOK 6,2M
-6% vs 2023
EBITDA margin
0.9%
-83% vs 2023
Equity ratio
18.3%
Financial strength
Net profit 2024
NOK 55K
-83% vs 2023
| Revenue | NOK 6,2M | -6% |
| EBITDA | NOK 55K | -83% |
| Net profit | NOK 55K | -83% |
| Total assets | NOK 2,6M | +29% |
| Equity | NOK 476K | +13% |
| Employees | 6 | — |
Legal name
BIOVITA AS
Org number
990631697
Legal form
Aksjeselskap
NACE code
4727 · Retail sale of other food
Founded
20. desember 2006
Share capital
NOK 200 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Dennis wauer
Company purpose
Kjøp og salg av medisinske produkter, kjøp og salg av handelsvarer, samt det som står i forbindelse med dette. Selskapet skal også kunne drive og delta i andre virksomheter med økonomisk formål.
Address
Holterkollveien 6, 1448 Drøbak
Phone
+4757721555
Email
post@biovita.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 11 933 | 9 169 | 6 830 | 6 605 | 6 217 |
| Staff expenses | −1 631 | −1 626 | −2 084 | −2 121 | −1 428 |
| EBITDA | 756 | −1 852 | −769 | 325 | 55 |
| Depreciation & amort. | −43 | −40 | −4 | −0 | −0 |
| EBIT | 713 | −1 892 | −773 | 325 | 55 |
| Net financials | −279 | 25 | −156 | −11 | 0 |
| Profit before tax | 434 | −1 867 | −928 | 314 | 55 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 434 | −1 867 | −928 | 314 | 55 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 142 | 2 845 | 1 765 | 2 017 | 2 607 |
| Equity | 4 636 | 1 035 | 107 | 421 | 476 |
| Long-term debt | 0 | 600 | 0 | 0 | 0 |
| Short-term debt | 2 505 | 1 210 | 1 658 | 1 596 | 2 131 |
| Total debt | 2 505 | 1 810 | 1 658 | 1 596 | 2 131 |
EBITDA margin
0.9%
This company
15.8%
Market median
-94% vs market
20202024
Equity ratio
18.3%
This company
38.2%
Market median
-52% vs market
20202024
Return on equity
11.5%
This company
18.4%
Market median
+37% vs market
20202024
Net profit margin
0.9%
This company
8.1%
Market median
-89% vs market
20202024
Asset turnover
2.39×
This company
1.12×
Market median
+113% vs market
20202024
Debt / equity
4.48×
This company
0.62×
Market median
-623% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DW Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2015 | |
| Chairman | 2015 | |
| Board of Directors | 2015 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 | |
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
D Wauer Holding As
BIOVITA AS Board members of BIOVITA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dennis Wauer | Chief Executive Officer | 0 companies |
| Svein Bentzen | Board of Directors | 0 companies |
| Tor Wauer | Chairman | 0 companies |
| Svein Bolkesjø Bentzen | Board of Directors | 0 companies |